USPTO serial 88031374
MIT
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUONG, ANGELA GAW
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ian W. Gillies
IAN W. GILLIES KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET14TH FLOORIRVINE, CA 92614Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical or biochemical products, namely, small molecules, probiotic bacteria, probiotic bacterial cultures, and/or microbes for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, and/or any disease or disorder associated with leaky gut; microbes, chemicals and/or biochemicals for use in the manufacture of pharmaceutical preparations, probiotic supplements, and/or nutritional supplements; probiotic bacteria, probiotic bacterial cultures, and/or biochemicals for in vitro scientific or research use | ABANDONED | — |
| 005 | Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, and/or any disease or disorder associated with leaky gut | ABANDONED | — |
| 042 | Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others | ABANDONED | — |
| 044 | Providing medical information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AXIAL THERAPEUTICS, INC.
- Other trademarks owned by Axial Biotherapeutics, Inc.
- Other trademarks owned by Axial Biotherapeutics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MIT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 24, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 17, 2019 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| Jul 17, 2019 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Jul 15, 2019 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jun 25, 2019 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 25, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 25, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 5, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 16, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 1, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 26, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 26, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 2, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 2, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 29, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 13, 2018 | NWAP | NEW APPLICATION ENTERED | — |